In focus · trending topic

ALNY investor fraud

2 stories · following the connections

ALNYLAM PHARMACEUTICALS INVESTOR REMINDER: Hagens Berman Reminds Investors in Alnylam Pharmaceuticals, Inc. of the Firm’s Investigation into Possible Securities Law Violations

By Nasdaq OMXOct 25, 2016, 1:30 PM UTC

ALNYLAM PHARMACEUTICALS INVESTOR ALERT: Hagens Berman is Investigating Possible Securities Law Violations by Alnylam Pharmaceuticals, Inc. and Officers

By Nasdaq OMXOct 6, 2016, 10:04 PM UTC